Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia
Clinical trial NCT05545111 · COMPLETED
Trial details
- NCT number
- NCT05545111
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-04
- Primary completion
- 2024-07-10
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.